ESMO-Magnitude of Clinical Benefit Scale (MCBS) group

Podobne zapisy

• Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules
  od: Dafni, Urania, i wsp.
  Wydane: (2017)
• Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring
  od: Gyawali, B., i wsp.
  Wydane: (2021)
• EHA evaluation of the ESMO—Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for haematological malignancies
  od: Kiesewetter, Barbara, i wsp.
  Wydane: (2020)
• Applying the ESMO-Magnitude of Clinical Benefit Scale in real life
  od: Ciardiello, Fortunato, i wsp.
  Wydane: (2016)
• Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) version 1.1
  od: Pichler, M., i wsp.
  Wydane: (2021)